Novo Nordisk’s once-weekly insulin loses FDA adcomm vote for type 1 diabetes
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Friday voted against the approval of Novo Nordisk’s once-weekly insulin icodec injection for type 1 diabetes.